APA (7th ed.) Citation

Moiseyenko, F. V., Moiseyenko, V. M., Aleksakhina, S. N., Chubenko, V. A., Volkov, N. M., Kozyreva, K. S., . . . Imyanitov, E. N. (2016). Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression. Oncology Research & Treatment, 39(10), 605. https://doi.org/10.1159/000449024

Chicago Style (17th ed.) Citation

Moiseyenko, Fedor V., et al. "Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib Until or Beyond Progression." Oncology Research & Treatment 39, no. 10 (2016): 605. https://doi.org/10.1159/000449024.

MLA (9th ed.) Citation

Moiseyenko, Fedor V., et al. "Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib Until or Beyond Progression." Oncology Research & Treatment, vol. 39, no. 10, 2016, p. 605, https://doi.org/10.1159/000449024.